Th. Kaltsas

817 total citations
11 papers, 578 citations indexed

About

Th. Kaltsas is a scholar working on Endocrinology, Diabetes and Metabolism, Pathology and Forensic Medicine and Surgery. According to data from OpenAlex, Th. Kaltsas has authored 11 papers receiving a total of 578 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Endocrinology, Diabetes and Metabolism, 5 papers in Pathology and Forensic Medicine and 2 papers in Surgery. Recurrent topics in Th. Kaltsas's work include Ophthalmology and Eye Disorders (5 papers), Pituitary Gland Disorders and Treatments (5 papers) and Growth Hormone and Insulin-like Growth Factors (5 papers). Th. Kaltsas is often cited by papers focused on Ophthalmology and Eye Disorders (5 papers), Pituitary Gland Disorders and Treatments (5 papers) and Growth Hormone and Insulin-like Growth Factors (5 papers). Th. Kaltsas collaborates with scholars based in Greece, Singapore and Denmark. Th. Kaltsas's co-authors include Nikolaos Pontikides, G. E. Krassas, Jane Paunković, Nebojša Paunković, Leonidas H. Duntas, Menelaos L. Batrinos, Jan Frystyk, G. Tolis, Allan Flyvbjerg and D. Lolis and has published in prestigious journals such as The Journal of Clinical Endocrinology & Metabolism, Human Reproduction and Clinical Endocrinology.

In The Last Decade

Th. Kaltsas

11 papers receiving 527 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Th. Kaltsas Greece 9 390 180 113 69 64 11 578
NORIO YOSHIKAWA Japan 16 303 0.8× 54 0.3× 44 0.4× 14 0.2× 104 1.6× 44 632
Giulia Lanzolla Italy 18 369 0.9× 440 2.4× 33 0.3× 134 1.9× 81 1.3× 41 726
Silvia Perrino Italy 9 284 0.7× 65 0.4× 42 0.4× 17 0.2× 37 0.6× 10 444
L Levin United States 10 68 0.2× 162 0.9× 53 0.5× 85 1.2× 52 0.8× 18 432
Concetta Coronella Italy 13 513 1.3× 75 0.4× 56 0.5× 20 0.3× 31 0.5× 14 657
Hüseyin Demirbilek Türkiye 19 453 1.2× 56 0.3× 110 1.0× 23 0.3× 234 3.7× 65 842
Nilusha Manji United Kingdom 4 508 1.3× 141 0.8× 10 0.1× 31 0.4× 52 0.8× 6 721
Haruo Tamaki Japan 15 483 1.2× 91 0.5× 59 0.5× 7 0.1× 69 1.1× 26 664
Piotr Miśkiewicz Poland 13 330 0.8× 261 1.4× 11 0.1× 100 1.4× 94 1.5× 41 584
Ronald Villanueva United States 11 478 1.2× 84 0.5× 182 1.6× 12 0.2× 118 1.8× 16 869

Countries citing papers authored by Th. Kaltsas

Since Specialization
Citations

This map shows the geographic impact of Th. Kaltsas's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Th. Kaltsas with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Th. Kaltsas more than expected).

Fields of papers citing papers by Th. Kaltsas

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Th. Kaltsas. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Th. Kaltsas. The network helps show where Th. Kaltsas may publish in the future.

Co-authorship network of co-authors of Th. Kaltsas

This figure shows the co-authorship network connecting the top 25 collaborators of Th. Kaltsas. A scholar is included among the top collaborators of Th. Kaltsas based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Th. Kaltsas. Th. Kaltsas is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
Krassas, G. E., et al.. (2003). Free and Total Insulin-Like Growth Factor (IGF)-I, -II, and IGF Binding Protein-1, -2, and -3 Serum Levels in Patients with Active Thyroid Eye Disease. The Journal of Clinical Endocrinology & Metabolism. 88(1). 132–135. 79 indexed citations
2.
Kaltsas, Th., et al.. (2003). Cyclical Cushing Syndrome Caused by Intermittent Ectopic ACTH Homogenesis Responsive to Somatostatin Analogues. The Endocrinologist. 13(1). 7–11. 1 indexed citations
3.
Pontikides, Nikolaos, et al.. (2000). Cabergoline as a First-Line Treatment in Newly Diagnosed Macroprolactinomas. Pituitary. 2(4). 277–281. 22 indexed citations
4.
Krassas, G. E., Nikolaos Pontikides, Th. Kaltsas, et al.. (1999). Disturbances of menstruation in hypothyroidism. Clinical Endocrinology. 50(5). 655–659. 175 indexed citations
6.
Krassas, G. E., Nikolaos Pontikides, & Th. Kaltsas. (1999). Giant Prolactinoma Presented as Unilateral Exophthalmos in a Prepubertal Boy: Response to Cabergoline. Hormone Research in Paediatrics. 52(1). 45–48. 30 indexed citations
7.
Kaltsas, Th., Nikolaos Pontikides, G. E. Krassas, et al.. (1999). Growth hormone response to thyrotrophin releasing hormone in women with polycystic ovarian syndrome. Human Reproduction. 14(11). 2704–2708. 7 indexed citations
8.
Kaltsas, Th., Nikolaos Pontikides, G. E. Krassas, et al.. (1998). Effect of gonadotrophin-releasing hormone agonist treatment on growth hormone secretion in women with polycystic ovarian syndrome. Human Reproduction. 13(1). 22–26. 14 indexed citations
9.
Krassas, G. E., et al.. (1997). Lanreotide in the treatment of patients with thyroid eye disease. European Journal of Endocrinology. 136(4). 416–422. 53 indexed citations
10.
Kaltsas, Th., et al.. (1995). Somatostatin receptor scintigraphy and octreotide treatment in patients with thyroid eye disease. Clinical Endocrinology. 42(6). 571–580. 92 indexed citations
11.
Krassas, G. E., et al.. (1994). Menstrual disturbances in thyrotoxicosis *. Clinical Endocrinology. 40(5). 641–644. 64 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026